Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 7
Submit an article Journal homepage
89
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Low dose melphalan in the treatment of myelofibrosis: A single centre experience

L. Chee Department of Haematology
,
R. Kalnins Department of Anatomical Pathology, Austin Hospital, Heidelberg, Victoria, Australia
&
Dr P. Turner Department of HaematologyCorrespondence[email protected]
Pages 1409-1412 | Accepted 23 Jan 2006, Published online: 01 Jul 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Giovanni Barosi, Vittorio Rosti & Alessandro M Vannucchi. (2011) Therapeutic approaches in myelofibrosis. Expert Opinion on Pharmacotherapy 12:10, pages 1597-1611.
Read now
Vincenzo Fontana, Pamela Dudkiewicz, Eugene R Ahn, Lawrence Horstman & Yeon S Ahn. (2011) Danazol therapy combined with intermittent application of chemotherapy induces lasting remission in myeloproliferative disorder (MPD): an alternative for the elderly with advanced MPD. Hematology 16:2, pages 90-94.
Read now

Articles from other publishers (3)

Alex Ganetsky. (2013) Ruxolitinib: A New Treatment Option for Myelofibrosis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33:1, pages 84-92.
Crossref
Tiziano BarbuiGiovanni BarosiGunnar BirgegardFrancisco CervantesGuido FinazziMartin GriesshammerClaire HarrisonHans Carl HasselbalchRudiger HehlmannRonald HoffmanJean-Jacques KiladjianNicolaus KrögerRuben MesaMary F. McMullinAnimesh PardananiFrancesco PassamontiAlessandro M. VannucchiAndreas ReiterRichard T. SilverSrdan VerstovsekAyalew Tefferi. (2011) Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet. Journal of Clinical Oncology 29:6, pages 761-770.
Crossref
Giovanni Barosi. 2011. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms 117 138 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.